Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2024-05-24 00:00:00 ET · period of report 2024-05-22 · accession 0001415889-24-014552 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-24 | 2024-05-22 | PTCT | ZELDIS JEROME B | Dir | S - Sale+OE | $38.24 | -20.0K | 14.5K | -58% | -$764.8K |
| D | 2024-05-24 | 2024-05-22 | PTCT | ZELDIS JEROME B | Dir | M - OptEx | $26.42 | +20.0K | 34.5K | +138% | +$528.4K |
| D | 2024-05-24 | 2024-05-22 | PTCT | ZELDIS JEROME B | Dir | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-22 | S | D | 20,000 | $38.24 | 14,500 | D | — | — | (F1) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $38.20 to $38.55 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-05-22 | M | A | 20,000 | $26.42 | 34,500 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-05-22 | M | D | 20,000 | $0.00 | 0 | D | $26.42 · — to 2024-07-31 | 20,000 Common Stock | (F2) Currently exercisable. |